FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to pharmacology, and concerns the use of 5-ethoxy 2-[2-(morpholino)ethylthio]-benzimidazole dihydrochloride (Afobazole) as an agent for correcting autism spectrum disorders.
EFFECT: reduced severity of main symptoms characteristic of autism spectrum disorders, wider range of drugs used in autism spectrum disorders and not having undesirable side effects.
1 cl, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATING AND PREVENTING DISORDERS OF AUTISM SPECTRUM | 2015 |
|
RU2608444C1 |
| AGENT IMPROVING PROCESS OF TRAINING, MEMORY AND COGNITIVE FUNCTIONS, AS WELL AS FOR SYMPTOMATIC THERAPY AT AUTISTIC DISORDERS | 2015 |
|
RU2612791C1 |
| METHOD FOR PERIPHERAL VISION PRIORITY DETERMINING, CHARACTERISTIC FOR PEOPLE WITH AUTISM SPECTRUM DISORDER | 2019 |
|
RU2724018C1 |
| CHROMINE DERIVATIVE AS DOPAMINE D3 RECEPTOR ANTAGONIST FOR APPLICATION IN TREATING AUTISM SPECTRUM DISORDER | 2014 |
|
RU2686110C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHILD SCHIZOPHRENIA AND CHILD AUTISM BY NUMBER OF COPIES OF GENES CODING RIBOSOMAL RNA IN GENOME OF CHILD WITH MENTAL DISORDERS | 2023 |
|
RU2816043C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF CHILDHOOD AUTISM OF MILD SEVERITY, ATYPICAL AUTISM AND SCHIZOPHRENIA IN CHILDREN | 2022 |
|
RU2808675C1 |
| LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
| METHOD FOR DIAGNOSING AUTISM SPECTRUM DISORDERS IN CHILDREN | 2022 |
|
RU2787463C1 |
| METHOD OF TEACHING CHILDREN WITH AUTISM SPECTRUM DISORDERS OF DIFFERENT DEGREE OF MANIFESTATION USING A MODEL OF A POLYSENSORY VIRTUAL-REAL-LIFE LEARNING SPACE | 2019 |
|
RU2722673C1 |
| METHOD OF DETERMINING THE NECESSITY OF USING PSYCHO PHARMACOTHERAPY AMONG THE PATIENTS WITH DISORDERS OF AUTIST SPECTRUM AT THE MOMENT OF THEIR EXAMINATION | 2017 |
|
RU2643760C1 |
